Sample exhibits significant inhibitory activity against Streptococcus pneumoniae and Cryptococcus neoformans and moderate activity against Neisseria gonorrhoeae.

Showing an impressive spectrum of action, this fraction effectively inhibits Streptococcus pneumoniae, a Gram-positive bacterium responsible for respiratory infections, and Cryptococcus neoformans, an opportunistic pathogen primarily affecting immunocompromised individuals, while its moderate activity against Neisseria gonorrhoeae provides a promising approach in the fight against sexually transmitted infections. Its broad spectrum of action makes it a promising candidate for developing therapies targeting both bacterial and fungal infections.

Know more about the pathogens